Healthy adults needed to test safety of experimental drug combo
NCT ID NCT07260851
First seen Jan 09, 2026 · Last updated Apr 28, 2026 · Updated 16 times
Summary
This early-stage study is testing the safety and how the body handles three experimental drugs (DWJ1622, DWC202313, DWC202314) in 40 healthy adults. Participants take the drugs under fasting conditions and are monitored closely. The goal is to gather basic safety and drug-level information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus YANGJI Hospital
RECRUITINGSeoul, Gwanak-gu, 08779, South Korea
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.